Many of our customers struggle with peptic ulcers and duodenal disorders caused by chronic Helicobacter pylori (H. pylori) infection.  These conditions vary greatly, and there are numerous recovery cases. However, a common characteristic is that the complete recovery of the  digestive system, which has suffered long-term damage from H. pylori, often requires considerable time. Compared to Western countries, Japan has a significantly higher prevalence of digestive diseases, particularly gastric and duodenal ulcers  caused by H. pylori. The effectiveness of antibiotics for eradication has drastically declined, and the issue of antibiotic-resistant strains has  become an increasingly serious problem.

In 1994, the World Health Organization (WHO) officially designated Helicobacter pylori as a definite carcinogen and issued a global  warning. H. pylori remains the only bacterium recognized as a direct carcinogen, highlighting the serious risks associated with its infection. Furthermore, eradication of H. pylori has become increasingly difficult. The success rate of antibiotic-based treatments has been declining over time,  and the emergence of antibiotic-resistant strains has become a widespread and alarming issue.

Governments and medical institutions must take Helicobacter pylori infections more seriously. Japan, in particular, has one of the highest  infection rates among developed countries, with at least half of the population estimated to be infected. In the past, the progression from gastritis → gastric ulcer → stomach cancer had an unknown cause. However, with the discovery of  H. pylori, it was confirmed that nearly 90% of these cases result from chronic H. pylori infection. The overuse of antibiotics and antimicrobial drugs is one of the most critical issues in Japan’s medical field.  As long as these antibiotics  continue to be used indiscriminately, the emergence of highly antibiotic-resistant strains of H. pylori will be inevitable. Since no effective treatments  exist for such resistant bacteria, this poses a serious medical threat.

The increase in drug-resistant bacteria due to artificial antimicrobial agents such as antibiotics is certainly a concern. However, the most critical  issue lies in the fact that resistance genes are spreading beyond bacterial species, rather than the increase of resistant bacteria themselves.  In reality, bacteria merely serve as carriers of these resistance genes. Considering this, the natural active substances in this product have mechanisms of action (bactericidal, bacteriostatic, and antiviral) that are  not found in conventional drugs. They completely avoid the issues of drug-resistant bacteria and side effects. Therefore, they are an ideal solution not  only for eradicating harmful intestinal bacteria, including Helicobacter pylori, but also for treating a wide range of diseases.  We are faced with the urgent need to seriously protect this natural bioactive substance.

Strong Manuka Honey MGO1050+ has a very broad antibacterial spectrum (range of effective bacterial species) against harmful and pathogenic  bacteria. It is highly effective not only in eradicating Helicobacter pylori but also in rapidly contributing to the treatment and prevention of diseases  caused by various pathogenic bacteria.

Furthermore, it exhibits significant sensitivity against multidrug-resistant bacteria that have acquired resistance to antibiotics, such as  hospital-acquired infections like MRSA (Methicillin-resistant Staphylococcus aureus) and VRE (Vancomycin-resistant Enterococcus). These resistant bacteria have emerged primarily due to the overuse of antibiotics, and their mechanism of action differs entirely from that of  natural active substances, which work through bactericidal, bacteriostatic, and antiviral mechanisms.

Due to its limited production volume and the balance of supply and demand, the price of this product has been rising. Many people agree that “as  honey, its price is extremely high.” However, a significant number of customers who have actually used the product recognize its true value. As a result, many continue to place  recurring orders through subscription plans, which offer priority access and special discounted benefits. As previously mentioned, there are no other products available—even in New Zealand, the sole production region—that surpass this product  in terms of MGO content, the key antibacterial and antiviral active component.

We are confident in the effectiveness of this exceptionally high-grade product, based on over 25 years of customer feedback and reports,  as well as numerous testimonials confirming its noticeable benefits even with a small intake.

■Reference: Customer Feedback Strong MANUKA HONEY | Manuka Honey from New Zealand’s Great Nature, Perfected by Japanese Craftsmanship

For Helicobacter pylori eradication, we recommend combining Strong Manuka Honey and Propolis Extract. To mix them, take approximately 10g of high-activating Manuka honey  using a large non-metallic spoon. Then, add about 10 drops of Propolis Extract. The mixture can be easily blended.

The combination use of these two substances can be expected to provide additive and synergistic benefits.
It is recommended to take this mixture three times a day, especially before bedtime.
Additionally, to maximize the active potency, please mix the ingredients fresh each time before consumption rather than preparing in advance.